Taiwan FDA registration 96d8ddd1de8dc9a7f010156ee279542f
“MAGSTIM” Repetitive transcranial magnetic stimulator (rTMS) System
TW: “美格思錠”重覆式經顱磁刺激治療系統
Taiwan·Risk Class 2·MD·THE MAGSTIM COMPANY LIMITED·Registered Mar 27, 2018 – Mar 27, 2028ActiveRegistration details
- Analysis ID
- 96d8ddd1de8dc9a7f010156ee279542f
- License Form
- Ministry of Health Medical Device Import No. 030972
- Customs Code
- DHA05603097206
Company information
- Manufacturer
- THE MAGSTIM COMPANY LIMITED
- Manufacturer Country
- United Kingdom
- Authorized Representative
- TRUSHINE MEDICAL INSTRUMENT CO., LTD.
Product details
- Intended Use
- It is used to treat patients with severe depression who do not respond well to drug therapy, and those adult patients who do not improve during the medication phase.
- Product Type (Level 1)
- K Devices for neuroscience
- Product Type (Level 2)
- K5805 Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment System
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Mar 27, 2018
- Expiry Date
- Mar 27, 2028
About this record
Access comprehensive regulatory information for “MAGSTIM” Repetitive transcranial magnetic stimulator (rTMS) System in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 96d8ddd1de8dc9a7f010156ee279542f and manufactured by THE MAGSTIM COMPANY LIMITED. The authorized representative in Taiwan is TRUSHINE MEDICAL INSTRUMENT CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices